Leads to Development opens new offices in London and Lyon

French company Leads To Development (L2D), a Paris-based specialist in the non-clinical development of novel therapeutics, is opening new offices in London and Lyon.

French company Leads To Development (L2D), a Paris-based specialist in the non-clinical development of novel therapeutics, is opening new offices in London in the UK and Lyon in France, as demand for its non-clinical development services continues to increase.

L2D is a pioneering business created to manage the non-clinical aspects of development projects, allowing biotech and pharmaceutical companies to bring in expertise as and when needed without having to build additional headcount and infrastructure.

All non-clinical development activities can be outsourced to L2D, which will manage part, or all, of the therapeutic programme from development plan design and writing through to the submission of the clinical trial application.

Non-clinical development encompasses all development activities required to be able to submit a clinical trial application, whatever the phase, including preclinical, as well as all the non-clinical aspects of phase I, II and